Table 2.

Cox regression model eGFR hazard ratios for all-cause and CVD mortality among patients with type 2 diabetes stratified by age using 65 years as cut-off and gender, with eGFR between 90 and 119 mL/min per 1.73 m² as reference (N = 36,556; years 2013–2019)

eGFR categories (mL/min per 1.73 m2)	< 65 years				≥65 years
	Number of Deaths (incidence rate (%) Malea)	Hazard Ratio (95% CI) Male	Number of Deaths (incidence rate (%) Femalea)	Hazard Ratio (95% CI) Female	Number of Deaths (incidence rate (%) Malea)	Hazard Ratio (95% CI) Male	Number of Deaths (incidence rate (%) Femalea)	Hazard Ratio (95% CI) Female
All-cause mortality
< 30	2 (31.25)	6.63 (1.64, 26.70)	5 (64.94)	22.88 (9.36, 55.94)	32 (66.12)	4.19 (2.86, 6.13)	42 (51.92)	6.90 (4.89, 9.74)
30 - < 60	17 (7.13)	1.44 (0.88, 2.38)	18 (9.23)	3.01 (1.84, 4.94)	333 (33.89)	2.05 (1.69, 2.47)	270 (23.65)	3.03 (2.47, 3.71)
60 - < 90	103 (5.54)	1.12 (0.88, 1.43)	53 (5.17)	1.68 (1.22, 2.32)	536 (20.19)	1.20 (1.00, 1.44)	489 (16.30)	2.06 (1.71, 2.49)
90 - < 120	172 (4.95)	1.00 (Reference)	127 (3.08)	1.00 (Reference)	152 (16.90)	1.00 (Reference)	141 (7.99)	1.00 (Reference)
CVD mortality
< 30	1 (15.63)	9.58 (1.33, 69.14)	3 (38.96)	59.64 (18.16, 195.91)	9 (18.60)	4.72 (2.28, 9.79)	17 (21.01)	14.43 (7.87, 26.48)
30 - < 60	8 (3.35)	1.98 (0.95, 4.15)	7 (3.59)	5.13 (2.25, 11.71)	95 (9.67)	2.38 (1.63, 3.48)	88 (7.71)	5.13 (3.33, 7.89)
60 - < 90	37 (1.99)	1.17 (0.78, 1.77)	12 (1.17)	1.67 (0.85, 3.27)	143 (5.39)	1.31 (0.91, 1.88)	118 (3.93)	2.59 (1.71, 3.94)
90 - < 120	59 (1.70)	1.00 (Reference)	29 (0.70)	1.00 (Reference)	37 (4.11)	1.00 (Reference)	27 (1.53)	1.00 (Reference)

Unadjusted model: Abbreviations: eGFR estimated glomerular filtration rate, CVD cardiovascular disease

^aThe incidence rate represented is for per 1000 person-years